Gene · 57492
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARID1B regulates sphingolipid metabolism and myelin development via STAG2: Mechanistic insights into ARID1B-related coffin-siris syndrome. | Cell Signal | 2026 | 41967622 | PubTator, text mining | PubMed |
| Intranasal exosome therapy in Coffin-Siris syndrome: Clinical evaluation of three children. | Surg Neurol Int | 2026 | 41952703 | PubTator, text mining | PubMed |
| Primary congenital glaucoma in a patient with Coffin-siris syndrome type 1 due to an ARID1B mutation: a novel association. | Ophthalmic Genet | 2026 | 41911953 | PubTator, text mining | PubMed |
| The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions. | Ann Hematol | 2026 | 41870600 | PubTator, text mining | PubMed |
| Molecular profiling of breast cancer in native American women reveals distinct genomic and transcriptomic features. | NPJ Precis Oncol | 2026 | 41844957 | PubTator, text mining | PubMed |
| Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer. | NPJ Precis Oncol | 2026 | 41826432 | PubTator, text mining | PubMed |
| ARID1A deficiency activates OSM-STAT3 axis in endometrial cancer, creating vulnerability to JAK/STAT3 inhibition. | Int J Biol Sci | 2026 | 41800254 | PubTator, text mining | PubMed |
| Expanding the Coffin-Siris syndrome spectrum: genetic, dysmorphic, and endocrine findings in eight cases. | Eur J Pediatr | 2026 | 41795723 | PubTator, text mining | PubMed |
| Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract: A Multi-Institutional Study. | Am J Surg Pathol | 2026 | 41775505 | PubTator, text mining | PubMed |
| Single-cell multi-omic techniques highlight the diverse composition and intercellular interactions of the vestibular schwannoma tumor microenvironment. | Neurooncol Adv | 2026 | 41769413 | PubTator, text mining | PubMed |
| Cancer Stemness and Dedifferentiation in Anaplastic Thyroid Carcinoma: Insights into a Multigenic, Microenvironmental Network and the Role of CD44. | Biomedicines | 2026 | 41751352 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Spatial Transcriptomics Coupled with Machine Learning Uncovers MORF4L1 as a Critical Epigenetic Mediator of Radiotherapy Resistance in Colorectal Cancer Liver Metastasis. | Biomedicines | 2026 | 41751172 | PubTator, text mining | PubMed |
| Identification of the Carcinogenic Process from Lobular Endocervical Glandular Hyperplasia to Gastric-Type Adenocarcinoma of the Uterine Cervix via Whole-Exome Sequencing. | Cancers (Basel) | 2026 | 41749904 | PubTator, text mining | PubMed |
| Gamma-Delta Hepatosplenic T-Cell Lymphoma in a Two-Year-Old: A Case Report. | Cureus | 2026 | 41732614 | PubTator, text mining | PubMed |
| Genetic-Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. | Epigenomes | 2026 | 41718408 | PubTator, text mining | PubMed |
| Effectiveness and Mechanism of Cryoablation in the Treatment of Oral Mucosal Melanoma. | Cancer Med | 2026 | 41652838 | PubTator, text mining | PubMed |
| Transarterial Chemoembolization Modulates the Exosomal miR-32-5p/cGAS-STING Axis Mediated Macrophage Ferroptosis, Triggers Immune Remodeling, and Enhances Anti-PD-1/L1 Efficacy in HCC. | Research (Wash D C) | 2026 | 41608526 | PubTator, text mining | PubMed |
| Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition. | Commun Biol | 2026 | 41606085 | PubTator, text mining | PubMed |
| Serum Levels of Wnt/β-catenin Pathway Regulators Dkk-1, PORCN, Notum, and Tiki-1 in Children with Autism Spectrum Disorder. | Clin Psychopharmacol Neurosci | 2026 | 41582471 | PubTator, text mining | PubMed |
| Acute leukemia with BCL11B rearrangements: Genetic landscape, BCL11B expression, and therapeutic response. | Hum Pathol | 2026 | 41581705 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57492/papers?page=2